– CNBC
Why Arcellx (ACLX) Stock Is Nosediving
Arcellx Inc (NASDAQ: ACLX) shares are trading lower by 8.50% to $32.76 Tuesday morning after the FDA on Monday put a clinical hold on the company's multiple myeloma phase 2 trial.
CNBC Halftime Report Final Trades: VanEck Semiconductor ETF, Chevron Corp, Qualcomm & The Carlyle Group
– CNBC
Related Posts
Comparative Study: Taiwan Semiconductor And Industry Competitors In Semiconductors & Semiconductor Equipment Industry
In today’s rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to…
Why Ascent Solar Shares Are Jumping Today
Ascent Solar Technologies, Inc (NASDAQ: ASTI) shares are trading higher after the company received encouragement from the U.S.
Abercrombie & Fitch Q4 Highlights: 3% Sales Growth, Bottom-Line Miss, Lower Inventories On Production Delays In Vietnam & More
Abercrombie & Fitch Co (NYSE:ANF) reported fourth-quarter FY22 sales growth of 3% year-on-year to $1.199 billion, beating the consensus of $1.18…